Gene expression profiling with DNA microarrays: Advancing our understanding of psychiatric disorders

Neurochemical Research

Volumn 27, Issue 10, 2002, Pages 1049-1063

  Pongrac, Julie ^a   Middleton, Frank A ^a   Lewis, David A ^a   Levitt, Pat ^a   Mirnics, Karoly ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Expression; Gene; Human; Microarray; Profiling; Psychiatric

Indexed keywords

ARTICLE; AUTOPSY; COMPLEX FORMATION; DNA MICROARRAY; GABAERGIC TRANSMISSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MENTAL DISEASE; MOLECULAR TYPING; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SECOND MESSENGER; TISSUE SPECIFICITY;

BRAIN; GENE EXPRESSION PROFILING; HUMANS; MENTAL DISORDERS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SCHIZOPHRENIA; SYNAPSES;

EID: 0036807851     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020904821237     Document Type: Article

References (136)

1. Ustun, T. B. and Chisholm, D. 2001. Global burden of disease - Study for psychiatric disorders. Psychiatr. Prax. 1:S7-S11.
2. Jablensky, A. 2000. Epidemiology of schizophrenia: The global burden of disease and disability. Eur. Arch. Psychiatr. Clin Neurosci. 250:274-285.
3. Baldessarini, R. J. 1996. Drugs and the treatment of psychiatric disorders. Pages 399-430, in Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., and Goodman Gilman, A. “eds”. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., McGraw-Hill, New York, NY.
4. Ban, T. A. 2001. Pharmacotherapy of mental illness - A historical analysis. Prog. Neuropsychopharmacol. Biol. Psychiatr. 25:709-727.
5. Buchanan, R. W. and Carpenter, W. T. 1994. Domain of psychopathology: An approach to the reduction of heterogeneity in schizophrenia. J. Nerv. Ment. Dis. 182:193-204.
6. Azorin, J. M. 1995. Long-term treatment of mood disorders in schizophrenia. Acta. Psychiatr. Scand. Suppl. 388:20-23.
7. Green, J. F. and King, D. J. 1996. Cognitive functioning in schizophrenia. CNS Drugs 6:382-398.
8. Krakowski, M., Czobor, P., and Volavka, J. 1997. Effect of neuroleptic treatment on depressive symptoms in acute schizophrenia episodes. Psychiatr. Res. 71:19-26.
9. Nakaya, M., Ohmori, K., Komahashi, T., and Suka, T. 1997. Depressive symptoms in acute schizophrenia inpatients. Schizophr. Res. 25:131-139.
10. Green, M. F. 1996. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatr. 153: 321-330.
11. Marder, S. R., Davis, J. M., and Chouinard, G. 1997. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. J. Clin. Psychiatr. 58:538-546.
12. Fleischhacker, W. W. and Hummer, M. 1997. Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimizing outcomes. Drugs 53:915-929.
13. Peuskens, J., Van Baelen, B., De Smedt, C., and Lemmens, P. 2000. Effects of risperidone on affective schizophrenia. Int. Clin. Psychopharmacol. 15:343-350.
14. Davis, J. M. and Chen, N. 2001. The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: Combined results of the North American and International Trials. J. Clin. Psychiatr. 62:757-771.
15. Glick, I. D., Lemmens, P., and Vester-Blokland, E. 2001. Treatment of the symptoms of schizophrenia: A combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents. Int. Clin. Psychopharmacol. 16: 265-274.
16. Vieta, E., Herraiz, M., Fernandez, A., Gasto, C., Benabarre, A., Colom, F., Martinez-Aran, A., and Reinares, M. 2001. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: Initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders “GSRAD”. J. Clin. Psychiatr. 62:623-630.
17. Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J. P., Cooper, T. B., Chakos, M., and Lieberman, J. A. 2002. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am. J. Psychiatr. 159: 255-262.
18. Allison, D. B., Mentore, J. L., and Moonseong, H. 1999. Antipsychotic-induced weight gain: A comprehensive research synthesis. Am. J. Psychiatr. 156:1686-1696.
19. Wetterling, T. and Mußigbrodt, H. E. 1999. Weight gain: Side effect of atypical neuroleptics? J. Clin. Psychopharmacol. 19: 316-321.
20. Osser, D. N., Najarian, D. M., and Dufresne, R. L. 1999. Olanzapine increases weight and serum triglyceride levels. J. Clin. Psychiatr. 60:767-770.
21. Hummer, M., Kemmler, G., and Kurz, M. 1995. Weight gain induced by olanzapine. Eur. Neuropsychopharmacol. 5:437-440.
22. Carnahan, R. M., Lund, B. C., and Perry, P. J. 2001. Ziprasidone, a new atypical antipsychotic drug. Pharmacotherapy 21:717-730.
23. Wirshing, D. A., Spellberg, B. J., and Erhart, S. M. 1998. Novel antipsychotics and new onset diabetes. Biol. Psychiatr. 44:778-783.
24. Kurzthaler, I. and Fleischhacker, W. W. 2001. The clinical implications of weight gain in schizophrenia. J. Clin. Psychiatr. 62:32-37.
25. Gutierrez, J. L. and del Rio Vega, J. M. 1997. Factors influencing relapse in the long-term course of schizophrenia. Schizophr. Res. 28:199.
26. Kane, J. M. 1999. Management strategies for the treatment of schizophrenia. J. Clin. Psychiatr. 60“S12”:13-17.
27. Lemmens, P., Brecher, M., and Van Baelen, B. 1999. A combined analysis of double-blind studies with risperidone versus placebo and other antipsychotic agents: Factors associated with extrapyramidal symptoms. Acta. Psychiatr. Scand. 99: 160-170.
28. Maurer, I. and Volz, H.-P. 2001. Cell-mediated side effects of psychopharmacological treatment. Arzneim-Forsch. Drug Res. 51:785-792.
29. Brown, P. O. and Bottenstein, D. 1999. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21S: 33-37.
30. Duggan, D. J., Bittner, M., Chen, Y., Meltzer, P., and Trent, J. M. 1999. Expression profiling using cDNA microarrays. Nat. Genet. 21S:10-14.
31. Cheung, V. G., Morley, M., Aguilar, F., Massimi, A., Kucherlapati, R., and Childs, G. 1999. Making and reading microarrays. Nat. Genet 21S:15-19.
32. Lipshutz, R. J., Fodor, S. P. A., Gingeras, T. R., and Lockhart, D. J. 1999. High density synthetic oligonucleotide arrays. Nat. Genet. 21S:20-24.
33. Schena, M. and Davis, R. W. 1999. Genes, genomes and chips. Pages 1-16, in Schena, M. “ed”. DNA Microarrays: A Practical Approach. Oxford University Press, Oxford, UK.
34. Drmanac, R., Labat, I., Brukner, I., and Crkvenjakov, R. 1989. Sequencing of megabase plus DNA by hybridization: Theory of the method. Genomics 4:114-128.
35. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. 1995. Serial analysis of gene expression. Science 270: 484-487.
36. Sutcliffe, J. G., Foye, P. E., Erlander, M. G., Hilbush, B. S., Bodzin, L. J., Durham, J. T., and Hasel, K. W. 2000. TOGA: An automated parsing technology for analyzing expression of nearly all genes. Proc. Natl. Acad. Sci. USA 97:1976-1981.
37. Brenner, S., Johnson, M., Bridgham, J., Golda, G., Lloyd, D. H., Johnson, D., Luo, S., McCurdy, S., Foy, M., Ewan, M., Roth, R., George, D., Eletr, S., Albrecht. G., Vermaas, E., Williams, S. R., Moon, K., Burcham, T., Pallas, M., DuBridge, R. B., Kirchner, J., Fearon, K., Mao, J.-I., and Corcoran, K. 2000. Gene expression analysis by massively parallel signature sequencing “MPSS” on mirobead arrays. Nat. Biotech. 18: 630-634.
38. Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470.
39. DeRisi, J., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y., Su, Y. A., and Trent. J. M. 1996. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14:457-460.
40. Lockhart, D. J., Dong, H., Byrne, M. C., Follette, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H., and Brown, E. L. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14:1675-1680.
41. Southern, E., Mir, K., and Shchepinov. M. 1999. Molecular interactions on microarrays. Nat. Genet. 21 S:5-9.
42. Geschwind, D. H., Gregg, J., Boone, K., Karrim, J., Pawlikowska-Haddal, A., Rao, E., Ellison, J., Ciccodicola, A., D'Urso, M., Woods, R., Rappold, G. A., Swerdloff, R., and Nelson, S. F. 1998. Klinefelter's syndrome as a model of anomalous cerebral laterality: Testing gene dosage in the X chromosome pseudoautosomal region using a DNA microarray. Dev. Genet. 23:215-229.
43. Kozal, M. J., Shah, N., Shen, N., Yang, R., Fucini, R., Merigan, T. C., Richman, D. D., Morris, D., Hubbell, E., Chee, M., and Gingeras, T. R. 1996. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat. Med. 2:753-759.
44. Cheung, V. G., Morley, M., Aguilar, F., Massimi, A., Kucherlapti, R., and Childs, G. 1999. Making and reading microarrays. Nat. Genet. 21S:20-32.
45. Mirnics, K., Lewis, D. A., and Levitt, P. 2001. DNA microarrays and human brain disorders. Pages 171-204, in Hermin, R. C. and Moldin, S. O. “eds.”. Chapter 8. Methods in Genomic Neuroscience, CRC Press, New York, NY.
46. Mirnics, K., Middleton, F. A., Lewis, D. A., and Levitt, P. 2001. Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse. Trends Neurosci. 24:479-486.
47. Marcotte, E. R., Srivastava, L. K., and Quirion, R. 2001. DNA microarrays in neuropsychopharmacology. Trends Pharmacol. Sci. 22:426-436.
48. Schena, M., Shalon, D., Heller, R., Chai, A., Brown, P. O., and Davis, R. W. 1996. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. USA 93:10614-10619.
49. DeRisi, J. F., lyer, V. R., and Brown, P. O. 1997. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278:680-686.
50. Whitney, L. W., Becker, K. G., Tresser, N. J., Caballero-Ramos, C. I., Munson, P. J., Prabhu, V. V., Trent, J. M., McFarland, H. F., and Biddleson, W. E. 1999. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 46:425-428.
51. Bertucci, F., Bernard, K., Loriod, B., Chang, Y.-C., Granjeaud, S., Birnbaum, D., Nguyen, C., Peck, K., and Jordan, B. R. 1999. Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum. Mol. Genet. 8:1715-1722.
52. Whitney, L. W. and Becker, K. G. 2001. Radioactived 33-P probes in hybridization to glass cDNA microarrays using neural tissues. J. Neurosci. Methods 106:9-13.
53. Barrett, T., Cheadle C., Wood, W. B., Teichberg, D., Donovan, D. M., Freed, W. J., Becker, K. G., and Vawter, M. P. 2001. Assembly and use of a broadly applicable neural cDNA microarray. Restor. Neurol. Neurosci. 18:127-135.
54. Chalifour, L. E., Fahmy, R., Holder, E. L., Hutchinson, E. W., Osterland, C. K., Schipper, H. M., and Wang, E. 1994. A method for analysis of gene expression patterns. Anal. Biochem. 216:299-304.
55. Zhao, N., Hashida, H., Takahashi, N., Misumi, Y., and Sakaki, Y. 1995. High-density cDNA filter analysis: A novel approach for large-scale quantitative analysis of gene expression. Gene 166:207-213.
56. Heller, R. A., Schena, M., Chai, A., Shalon, D., Bedilion, T., Gilmor, J., Wooley, D. E., and Davis, R. W. 1997. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc. Natl. Acad. Sci. USA 94:2150-2155.
57. Lockhart, D. J. and Barlow, C. 2001. DNA arrays and gene expression analysis in the brain. Pages 143-170, in Chin, H. R. and Moldin, S. O. “eds.”. Chapter 7. Methods in Genomic Neuroscience, CRC Press, New York, NY.
58. Zhou, X., Gao, X., LeProust, E., Phillippe, P., Yu, P., Zhang, H., Gulari, E., Srivannavit, O., and Gulari, N. 1999. Light-directed, programmable microarray synthesis. Nat. Med. 23:84.
59. Singh-Gasson, S., Green, R. D., Yue, Y., Nelson, C., Blattner, F., Sussman, M. R., and Cerrina, F. 1999. Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array. Nat. Biotech. 17:974-978.
60. Watson, S. J., Meng, F., Thompson, R. C., and Akil, H. 2000. The "Chip" as a specific genetic tool. Biol. Psychiatr. 48: 1147-1156.
61. Luo, Z. and Geschwind, D. H. 2001. Microarray applications in neuroscience. Neurobiol. Dis. 8:183-193.
62. Bahn, S., Augood, S. J., Ryan, M., Standaert, D. G., Starkey, M., and Emson, P. C. 2001. Gene expression profiling in the post-mortem human brain - No cause for dismay. J. Chem. Neuroanat. 22:79-94.
63. Harrison, P. J., Heath, P. R., Eastwood, S. L., Burnet, P. W. J., McDonald, B., and Pearson, R. C. A. 1995. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200:151-154.
64. Barton, A. J., Pearson, R. C., Najlerahim, A., and Harrison, P. J. 1993. Pre- and postmortem influences on brain RNA. J. Neurochem. 61:1-11.
65. Geschwind, D. H., Ou, J., Easterday, M. C., Dougherty, J. D., Jackson, R. L., Chen, Z., Antoine, H., Terskikh, A., Weissman, I. L., Nelson, S. F., and Kornblum, H. I. “2001” A genetic analysis of neural progenitor differentiation. Neuron 29:325-339.
66. Mimmack, M. L., Ryan, M., Baba, H., Navarro-Ruiz, J., Iritani, S., Faull, R. L. M., McKenna, P. J., Jones, P. B., Arai, H., Starkey, M., Emson, P. C., and Bahn, S. 2002. Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. 99:4680-4685.
67. Mirnics, M. L. and Lewis, D. A. 2001. Genes and subtypes of schizophrenia. Trends Mol. Med. 2:444-447.
68. Mirnics, K. 2001. Microarrays in brain research: The good, the bad and the ugly. Nat. Rev. Neurosci. 2:444-447.
69. Miles, M. F. 2001. Microarrays: Lost in a storm of data? Nat. Rev. Neurosci. 2:441-443.
70. Becker, K. G. 2001. The sharing of cDNA microarray data. Nat. Rev. Neurosci. 2:438-440.
71. Geschwind, D. H. 2001. Sharing gene expression data: An array of options. Nat. Rev. Neurosci. 2:435-438.
72. Middleton, F. A., Mirnics, K., Pierri, J. N., Lewis, D. A., and Levitt, P. 2002. Gene expression in profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22:2718-2729.
73. Wodicka, L., Dong, H., Mittmann, M., Ho, M. H., and Lockhart, D. J. 1997. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat. Biotechnol. 15:1359-1367.
74. Kane, M. D., Jatkoe, T. A., Stumpf, C. R. Lu, J., Thomas, J. D., and Madore, S. J. 2000. Assessment of sensitivity and specificity of oligonucleotide “50 mer” microarrays. Nuc. Acids Res. 28:4522-4577.
75. Winfield, D. A., Gatter, K. C., and Powell, T. P. 1980. An electron microscopic study of the types and proportions of neurons in the cortex of the motor and visual areas of the cat and rat. Brain 103:245-258.
76. Olsen, M. K., Kawabe, T. T., Gotow, L. F., Burr, J. E., Vidmar, T. J., Merchant, K. M., Buhl, A. E., and Roberds, S. L. 2001. Haloperidol-induced genes in rat dorsolateral striatum detected using laser capture microdissection and Affymetrix microrarrays. Soc. Neurosci., Abstr., Vol. 27, Program No. 495.3.
77. Mirnics, K. 2002. Mircroarrays in brain research: Data quality and limitations. Curr. Genomics 3:13-20.
78. Li, C. and Wong, W. H. 2001. Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc. Natl. Acad. Sci. 98:31-36.
79. Whitney, L. W., Ludwin, S. K., McFarland, H. F., and Biddison, W. E. 2001. Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J. Neuroimmunol. 121: 40-48.
80. Ginsberg, S. D., Crino, P. B., Scott, E. H., Weingarten, J. A., Virginia, M.-Y. L., Eberwine, J. H., and Trojanowski, J. Q. 1999. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann. Neurol. 45:174-181.
81. Ginsberg, S. D., Hemby, S. E., Lee, V. M.-Y., Eberwine, J. H., and Trojanowski, J. Q. 2000. Expression profile of transcripts in Alzheimer's disease tangle-bearing CAI neurons. Ann. Neurol. 48:77-87.
82. Mufson, E. J., Ginsberg, S. D., Ikonomovic, M. D., and DeKosky, S. T. 2002. Molecular pathology of the cholinotrophic basocortical system in elderly people with mild cognitive impairment. Neurobiol. Aging Suppl., in press.
83. Purcell, A. E., Jeon, O. H., Zimmerman, A. W., Blue, M. E., and Pevsner, J. 2001. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57: 1618-1628.
84. Hata, R., Masumura, M., Akatsu, H., Li, F., Fujita, H., Nagai, Y., Yamamoto, T., Okada, H., Kosaka, K., Sakanaka, M., and Sawasada, T. 2001. Up-regulation of calcineurin Aβ mRNA in the Alzheimer's disease brain: Assessment by cDNA microarray. Biochem. Biophysic. Res. Comm. 284:310-316.
85. Ho, L., Guo, Y., Spielman, L., Petrescu, O., Haroutunian, V., Purohit, D., Czernik, A., Yemul., S., Aisen, P. S., Mohs, R., and Pasinetti., G. M. 2001. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neuroscience Lett. 298:191-194.
86. Pasinetti, G. M. 2001. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J. Neurosci. Res. 65:471-476.
87. +, oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 76:1010-1021.
88. Grunblatt, E., Mandel, S., Maor, G., and Youdim, M. B. H. 2001. Gene expression analysis in N-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine. J. Neurochem. 78:1-12.
89. Mandel, S., Grunblat, E., and Youdim, M. 2000. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: Implications for idiopathic Parkinson's disease. J. Neural. Transm. Suppl. 60:117-124.
90. Niculescu, A. B., 3rd and Kelsoe, J. R. 2001. Convergent functional genomics: Application to bipolar disorder. Ann. Med. 33: 263-271.
91. Detera-Wadleigh, S. D. 2001. Lithium-related genetics of bipolar disorder. Ann. Med. 33:272-285.
92. Kabbaj, M., Evans, S., Selwood, S. P., Watson, S. J., Murphy, G., and Akil, H. 2001. Individual differences in the effect of social defeat on hippocampal gene expression: A microarray study in rats. Soc. Neurosci. Abstr. Vol. 27, Program No. 176.17.
93. Murphy, G. M., Jr., Pollock, B. G., Kirshner, M. A., Pascoe, N., Cheuk, W., Mulsant, B. H., and Reynolds, C. F., 3rd. 2001. CYP2D6 genotyping with oligonucleotide microarrays and nortriptyline concentrations in geriatric depression. Neuropsychopharmacology. 25:737-473.
94. Yamada, M., Yamada, M., Yamazaki, S., Takahashi, K., Nara, K., Ozawa, H., Yamada, S., Kiuchi, Y., Oguchi, K., Kamijima, K., Higuchi, T., and Momose, K. 2001. Induction of cysteine string protein after chronic antidepressant treatment in frontal cortex. Neurosci. Lett. 301:183-186.
95. Manji, H. K. and Chen, G. 2002. Modulation of Neurotrophic Signaling Cascades by Mood Stabilizing Agent: Putative Mediators of Long Term Therapeutic Effects in Bipolar Disorder. Stanley Foundation, Washington, DC, Abstr.
96. Marcotte, E. R., Quirion, R., and Srivastava, L. K. 2000. Gene expression changes in adult prefrontal cortex and nucleus accumbens following neonatal ventral hippocampal lesions. Soc. Neurosci. Abstr. Vol. 26, Program No. 1038.
97. Lewis, D. A. and Lieberman, J. A. 2000. Catching up on schizophrenia: Natural history and neurobiology. Neuron 28:325-334.
98. Carpenter, W. T. and Buchanan, R. W. 1994. Schizophrenia. New Eng. J. Med. 330:681-690.
99. Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., and Levitt, P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
100. Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., and Levitt, P. 2001. Disease-specific changes in regulator of G-protein signaling 4 “RGS4” expression in schizophrenia. Mol. Psychiatr. 6:293-301.
101. Gold, S. J., Ni, Y. G., Dohlman, H. G., and Nestler, E. J. 1997. Regulators of G-protein signaling “RGS” proteins: Region-specific expression of nine subtypes in rat brain. J. Neurosci. 17:8024-8037.
102. Zheng, B., De Vries, L., and Gist Farquhar, M. 1999. Divergence of RGS proteins: Evidence for the existence of six mammalian RGS subfamilies. Trends Biochem. Sci. 24:411-414.
103. DeVries, L. and Gist Farquhar, M. 1999. RGS proteins: More than just GAPs for heterotrimetric G proteins. Trends Cell Biol. 9:138-140.
104. DeVries, L., Zheng, B., Fischer, T., Elenko, E., and Farquhar, M. G. 2000. The regulator of G-protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40:235-221.
105. Berman, D. M., Kozasa, T., and Gilman, A. G. 1996a. The GT-Pase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J. Biol. Chem. 271:27209-27212.
106. Berman, D. M., Wilkie, T. M., and Gilman, A. G. 1996b. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86:445-452.
107. Chowdari, K. V., Mirnics, K., Semwal, P., Wood, J., Lawrence, E., Bhatia, T., Deshpande, S. N., Thelma, B. K., Ferrell, R. E., Middleton, F. A., Devlin, B., Levitt, P., Lewis, D. A., and Nimgaonkar, V. L. 2002. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 12:1-8.
108. Brzustowicz, L. M., Hodgkinson, K. A., Chow, E. W., Honer, W. G., and Bassett, A. S. 2000. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288:678-682.
109. Jope, R. S., Ling, S., Grimes, C. A., Pacheco, M. A., Dilley, G. E., Li, X., Meltzer, H. Y., Overholser, J. C., and Stockmeier, C. A. 1998. Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence. J. Neurochem. 70: 763-771.
110. Lin, X.-H., Kitamura, N., Hashimoto, T., Shirakawa, O., and Meada, K. 1999. Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia. Biol. Psychiatr. 46:1665-1671.
111. Nishino, N., Kitamura, N., Hashimoto, T., Kjimoto, Y., Shirai, Y., Murakami, N., Nakai, T., Komure, O., Shirakawa, O., Mita, T., et al. 1993. Increase in [3H]cAMP binding sites and decrease in Gi alpha and Go alpha immunoreactivities in left temporal cortices from patients with schizophrenia. Brain Res. 615:41-49.
112. Dean, B., Opeskin, K. Pavey, G., Hill, C., and Keks, N. 1997. Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia. J. Neural Transm. 104:1371-1381.
113. Sklar, P. 2001. Microarray analysis of the Stanley brain collection. In 7th Symposium on the Neurovirology and Neuroimmunology of Schizophrenia and Bipolar Disorder, Stanley Foundation, Washington, DC, Abstr.
114. Kass, S. U., Van den Wyngaert, I., Goehlmann, H., de Vries, W., Nicholl, D., and Dillen, L. 2001. Proteomics and genomics approaches for the identification of targets in psychiatric diseases. In 5th Dutch Endo-Neuro Meeting, Abstr.
115. Vawter, M. P., Barrett, T., Cheadle, C., Skolov, B. P., Wood, W. H., III, Donovan, D. M., Webster, M., Freed, W. J., and Becker, K. G. 2001. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 55:641-650.
116. Vawter, M. P. 2001. Preliminary screening of gene expression in schizophrenia by cDNA microarray. In 7th Symposium on the neurovirology and neuroimmunology of schizophrenia and bipolar disorder, Stanley Foundation, Washington, DC, Abstr.
117. Feron, F. 2001. Microarray studies - An integrative platform for case-control studies and animal models of schizophrenia. In 7th Symposium on the neurovirology and neuroimmunology of schizophrenia and bipolar disorder, Stanley Foundation, Washington, DC, Abstr.
118. Hemby, S. E., Ginsberg, S. D., Brunk, B., Arnold, S. E., Trojanowski, J. Q., and Eberwine, J. H. 2002. Gene expression profile for schizophrenia: Discrete neuron transcription patterns in the entorhinal cortex. Arch. Gen. Psychiat. 59:631-640.
119. Hakak, Y., Walker, J. R., Cheng, L., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., and Fienberg, A. A. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. 98:4746-4751.
120. Pierri, J. N., Chaudry, A. S., Woo, T.-U., and Lewis, D. A. 1999. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenia subjects. Am. J. Psychiatr. 156:1709-1719.
121. Schneider, A., Montague, P., Griffiths, I., Fanarraga, M., Kennedy, P., Brophy, P., and Nave, K. A. 1992. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358:758-761.
122. OMIM; Online Mendelian Inheritance in Man, OMIM “TM”. 2000. McKusick-Nathans Institute for Genetic Medicine, John Hopkins University “Baltimore, MD” and National Center for Biotechnology Information, National Library of Medicine “Bethesda, MD”.
123. Nave, K. A., Lai, C., Bloom, F. E., and Milner, R. J., 1986. Jimpy mutant mouse: A 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc. Natl. Acad. Sci. USA 83:9264-9268.
124. Nave, K. A., Lai, C., Bloom, F. E., and Milner, R. J. 1987. Splice site selection in the proteolipid protein “PLP” gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc. Natl. Acad. Sci. USA 84:5665-5669.
125. Hudson, L. D., Berndt, J. A., Puckett, C., Kozak, C. A., and Lazzarini, R. A. 1987. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc. Natl. Acad. Sci. USA 84:1454-1458.
126. Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., and Liotta, L. A. “1996” Laser capture microdissection. Science 274:998-1001.
127. Luo, L., Salunga, R. C., Guo, H., Bittner, A., Joy, K. C., Galindo, J. E., Xiao, H., Rogers, K. E., Wan, J. S., Jackson, S. W., Jackson, M. R., and Erlander, M. G. 1999. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat. Med. 5:117-122.
128. Banks, R. E., Dunn, M. J., Forbes, M. A., Stanley, A., Pappin, D., Naven, T., Gough, M., Harnden, P., and Selby, P. J. 1999. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis Preliminary findings. Electrophoresis 20:680-700.
129. Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. and Weinberger, D. R. 2001. Effect of COMT Va1108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA 98:6917-6922.
130. Livesey, F. J., Furukawa, T., Steffen, M. A., Church, G. M., and Cepko, C. L. 2000. Microarray analysis of the transcriptional network controlled by the photoreceptor homeobox gene Crx. Curr. Biol. 10:301-310.
131. Kielbasa, S. M., Korbel, J. O., Beule, D., Schuchhardt, J., and Herzel, H. 2001. Combining frequency and positional information to predict transcription factor binding sites. Bioinformatics 17:1019-1026.
132. Smith, D. J. 2001. Chips for brains. Curr. Genomics 3:1-6.
133. Stoeckert, C., Pizarro, A., Manduchi, E., Gibson, M., Brunk, B., Crabtree, J., Schug, J., Shen-Orr, S., and Overton, G. C. 2001. A relational schema for both array-based and SAGE gene expression experiments. Bioinformatics 17;300-308.
134. Gardiner-Garden, M. and Littlejohn, T. G. 2001. A comparison of microarray databases. Brief Bioinform. 2:143-158.
135. Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., Gaasterland, T., Glenisson, P., Holstege, F. C., Kim, I. F., Markowitz, V., Matese, J. C., Parkinson, H., Robinson, A., Sarkans, U., Schulze-Kremer, S., Stewart, J., Taylor, R., Vilo, J., and Vingron, M. 2001. Minimum information about a microarray experiment “MIAME”-toward standards for microarray data. Nat. Genet. 29:365-371.
136. Edgar, R., Domrachev, M., and Lash, A. E. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30:207-210.